**Core Concept**
Febuxostat is a xanthine oxidase inhibitor, which is a class of medications used to treat high levels of uric acid in the blood, a condition known as hyperuricemia. This condition can lead to the development of gout, a type of inflammatory arthritis.

**Why the Correct Answer is Right**
Febuxostat works by inhibiting the enzyme xanthine oxidase, which is responsible for the production of uric acid in the body. By blocking this enzyme, febuxostat reduces the production of uric acid, which helps to lower serum uric acid levels and alleviate symptoms of gout. Febuxostat is also used to prevent recurrent gout attacks in patients who have had at least two attacks in the preceding 12 months.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because febuxostat is not a uricosuric agent, which is a class of medications that increases the excretion of uric acid in the urine.
**Option B:** This option is incorrect because febuxostat is not primarily used to treat hyperlipidemia or dyslipidemia.
**Option C:** This option is incorrect because febuxostat is not a prostaglandin inhibitor, which is a class of medications used to reduce inflammation in conditions such as rheumatoid arthritis.

**Clinical Pearl / High-Yield Fact**
Febuxostat is a useful alternative to allopurinol for patients who are unable to tolerate the gastrointestinal side effects of allopurinol. However, febuxostat may increase the risk of cardiovascular events in patients with a history of cardiovascular disease.

**Correct Answer: D. Treatment of gout.**